Nu Holdings Ltd. is a strong buy with significant growth in Latin America, profitability, and a low P/E of 15x 2026 EPS.

Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.

Based on the terms of the agreement, BridgeBio will receive a $30 million milestone payment upon approval in Japan, as well ...

JP Morgan sees strong growth for Ascentage Pharma, citing its late-stage cancer drugs. The biotech's 2024 sales surged 342% ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where aTyr ...

We recently published a list of Jim Cramer Discussed These 6 Stocks Recently. In this article, we are going to take a look at ...

We recently published a list of the 12 Best AI Stocks to Invest in According to Reddit. In this article, we are going to take ...

Armata Pharmaceuticals, Inc.’s ARMP share price has surged by 10.02%, which has investors questioning if this is right time to sell.

While the US biotechnology sector has swooned on concerns about new US healthcare policies, the ASX 'Magnificent Seven' has soared.

The developer of a spray-based erectile dysfunctional treatment, LTR Pharma has found a pre-approval route to the US market.

Merck & Co. is flexing its pharmaceutical muscles with strong dividend growth, steady cash flow, and a blockbuster cancer ...

Advisors Asset Management Inc. trimmed its stake in Regeneron Pharmaceuticals by 7.9%, selling 443 shares in the fourth ...